Annual CFI
-$403.78 M
-$402.64 M-35443.93%
December 31, 2022
Summary
- As of February 10, 2025, RXDX annual cash flow from investing activities is -$403.78 million, with the most recent change of -$402.64 million (-35443.93%) on December 31, 2022.
- During the last 3 years, RXDX annual CFI has fallen by -$411.71 million (-5189.87%).
Performance
RXDX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
-$192.33 M
+$27.87 M+12.66%
March 31, 2023
Summary
- As of February 10, 2025, RXDX quarterly cash flow from investing activities is -$192.33 million, with the most recent change of +$27.87 million (+12.66%) on March 31, 2023.
- Over the past year, RXDX quarterly CFI has dropped by -$191.38 million (-20039.58%).
Performance
RXDX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
-$595.16 M
-$191.38 M-47.40%
March 31, 2023
Summary
- As of February 10, 2025, RXDX TTM cash flow from investing activities is -$595.16 million, with the most recent change of -$191.38 million (-47.40%) on March 31, 2023.
- Over the past year, RXDX TTM CFI has dropped by -$593.36 million (-33093.36%).
Performance
RXDX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RXDX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | -10000.0% | -10000.0% |
| 3 y3 years | -5189.9% | -10000.0% | -10000.0% |
| 5 y5 years | -5189.9% | -10000.0% | -10000.0% |
RXDX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | >+9999.0% | at low | >+9999.0% | +14.5% | >+9999.0% | at low |
| 5 y | 5-year | -5189.9% | at low | <-9999.0% | +14.5% | >+9999.0% | at low |
| alltime | all time | -5189.9% | at low | <-9999.0% | +14.5% | >+9999.0% | at low |
Prometheus Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$192.33 M(-12.7%) | -$595.16 M(+47.4%) |
| Dec 2022 | -$403.78 M(>+9900.0%) | -$220.20 M(+234.9%) | -$403.78 M(+119.7%) |
| Sep 2022 | - | -$65.76 M(-43.7%) | -$183.77 M(+55.2%) |
| Jun 2022 | - | -$116.86 M(>+9900.0%) | -$118.37 M(+6502.0%) |
| Mar 2022 | - | -$955.00 K(+402.6%) | -$1.79 M(+57.8%) |
| Dec 2021 | -$1.14 M | -$190.00 K(-48.1%) | -$1.14 M(+279.9%) |
| Sep 2021 | - | -$366.00 K(+29.8%) | -$299.00 K(-41.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$282.00 K(-5.4%) | -$515.00 K(+64.5%) |
| Mar 2021 | - | -$298.00 K(-146.1%) | -$313.00 K(-70.6%) |
| Dec 2020 | -$1.06 M(-113.4%) | $647.00 K(-211.2%) | -$1.06 M(-37.8%) |
| Sep 2020 | - | -$582.00 K(+627.5%) | -$1.71 M(+51.6%) |
| Jun 2020 | - | -$80.00 K(-92.4%) | -$1.13 M(+7.6%) |
| Mar 2020 | - | -$1.05 M | -$1.05 M |
| Dec 2019 | $7.93 M | - | - |
FAQ
- What is Prometheus Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Prometheus Biosciences?
- What is Prometheus Biosciences annual CFI year-on-year change?
- What is Prometheus Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly CFI year-on-year change?
- What is Prometheus Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Prometheus Biosciences?
- What is Prometheus Biosciences TTM CFI year-on-year change?
What is Prometheus Biosciences annual cash flow from investing activities?
The current annual CFI of RXDX is -$403.78 M
What is the all time high annual CFI for Prometheus Biosciences?
Prometheus Biosciences all-time high annual cash flow from investing activities is $7.93 M
What is Prometheus Biosciences annual CFI year-on-year change?
Over the past year, RXDX annual cash flow from investing activities has changed by -$402.64 M (-35443.93%)
What is Prometheus Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of RXDX is -$192.33 M
What is the all time high quarterly CFI for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly cash flow from investing activities is $647.00 K
What is Prometheus Biosciences quarterly CFI year-on-year change?
Over the past year, RXDX quarterly cash flow from investing activities has changed by -$191.38 M (-20039.58%)
What is Prometheus Biosciences TTM cash flow from investing activities?
The current TTM CFI of RXDX is -$595.16 M
What is the all time high TTM CFI for Prometheus Biosciences?
Prometheus Biosciences all-time high TTM cash flow from investing activities is -$299.00 K
What is Prometheus Biosciences TTM CFI year-on-year change?
Over the past year, RXDX TTM cash flow from investing activities has changed by -$593.36 M (-33093.36%)